Provided by Tiger Trade Technology Pte. Ltd.

Solid Biosciences

5.38
-0.4400-7.56%
Post-market: 5.380.00000.00%16:53 EST
Volume:961.63K
Turnover:5.34M
Market Cap:419.16M
PE:-2.40
High:6.00
Open:5.84
Low:5.34
Close:5.82
52wk High:7.37
52wk Low:2.41
Shares:77.91M
Float Shares:37.61M
Volume Ratio:1.24
T/O Rate:2.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2440
EPS(LYR):-3.0550
ROE:-86.83%
ROA:-43.67%
PB:1.92
PE(LYR):-1.76

Loading ...

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Nov 05

Solid Biosciences Is Maintained at Buy by Chardan Capital

Dow Jones
·
Nov 04

Solid Biosciences’ SGT-003 Therapy Shows Promising Efficacy and Safety, Earning a Buy Rating

TIPRANKS
·
Nov 04

Solid Biosciences price target lowered to $9 from $10 at Barclays

TIPRANKS
·
Nov 04

Solid Biosciences Reports Q3 2025 Results and Clinical Progress

TIPRANKS
·
Nov 04

Solid Biosciences Reports Positive Interim Data on SGT-003

TIPRANKS
·
Nov 04

Solid Biosciences Q3 EPS $(0.48) Misses $(0.43) Estimate

Benzinga
·
Nov 04

Solid Biosciences Reports Third Quarter 2025 Financial Results and Provides Update on Inspire Duchenne Clinical Trial Progress and Planned Regulatory Discussions

THOMSON REUTERS
·
Nov 04

Press Release: Solid Biosciences Reports Third Quarter 2025 Financial Results and Provides Update on INSPIRE DUCHENNE Clinical Trial Progress and Planned Regulatory Discussions

Dow Jones
·
Nov 04

Solid Biosciences Inc expected to post a loss of 44 cents a share - Earnings Preview

Reuters
·
Nov 01

Solid Biosciences to Participate at Upcoming Investor Conferences

GlobeNewswire
·
Oct 30

William Blair Sticks to Their Buy Rating for Solid Biosciences (SLDB)

TIPRANKS
·
Oct 14

Solid Biosciences to Present at Upcoming Scientific Meetings

GlobeNewswire
·
Oct 01

Solid Biosciences to Present at 2025 Neuromuscular Study Group Annual Scientific Meeting

GlobeNewswire
·
Sep 25

Solid Biosciences: Strategic Collaborations and Regulatory Progress Drive Buy Rating

TIPRANKS
·
Sep 24

Solid Biosciences announces licensing agreement with Kinea Bio

TIPRANKS
·
Sep 23

Solid Biosciences Announces Licensing Agreement With Kinea Bio for the Use of Proprietary Next-Generation Capsid Aav-Slb101

THOMSON REUTERS
·
Sep 23

Solid Biosciences Announces Licensing Agreement with Kinea Bio for the Use of Proprietary Next-Generation Capsid AAV-SLB101

GlobeNewswire
·
Sep 23

Cantor Fitzgerald Sticks to Their Buy Rating for Solid Biosciences (SLDB)

TIPRANKS
·
Sep 23

Citizens JMP Sticks to Their Buy Rating for Solid Biosciences (SLDB)

TIPRANKS
·
Sep 12